1700 Owens St. Suite 515
San Francisco, CA 94158
Dedicated to discovering and developing novel therapeutics through clinical proof-of-concept.
The Company's strong
business model, its core leadership and drug development team enable efficient use of resources and capital, and creation of strong IP leading to early clinical proof-of-concept and successful exits.
Founded by a group of accomplished biopharmaceutical professionals who have collaborated extensively on early-stage drug discovery and development projects.
PHT has the resources to identify strong preclinical therapeutic opportunities with addressable markets, valid science, druggable targets, and clear regulatory precedent.
Potrero Hill Therapeutics